NICER: A safer alternative to CRISPR/Cas9 for gene editing

The gene editing technique CRISPR/Cas9 has allowed researchers to make precise and impactful changes to an organism’s DNA to fix mutations that cause genetic disease.

Long COVID May Be Difficult to Identify in MS

WEST PALM BEACH, Fla. – People with multiple sclerosis (MS) appeared to have a low risk of developing long COVID, but lingering complaints after SARS-CoV-2

March 3, 2024

MIT scientists look to unlock potential of ‘self-adjuvanting’ mRNA vaccines in mice

Scientists at MIT have revamped mRNA Covid jabs to boost their immune responses, potentially paving the way for work on a new class of “self-adjuvanting”

September 9, 2023

Presented results suggest eating primarily minimally processed foods does not make for a healthy diet

A new study demonstrates that eating primarily minimally processed foods, as they are defined by the NOVA classification system, does not automatically make for a

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.